{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:46:16Z","timestamp":1782413176573,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11102-026-01682-w","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:38:49Z","timestamp":1776685129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["External validation of the PANOMEN-3 classification for predicting 1-year surgical remission in pituitary adenoma"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-6529","authenticated-orcid":false,"given":"Ozan","family":"Baskurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-8628","authenticated-orcid":false,"given":"Nurperi","family":"Gazioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"1682_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-023-00883-8","volume":"19","author":"KKY Ho","year":"2023","unstructured":"Ho KKY, Kaiser UB, Chanson P et al (2023) Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat Rev Endocrinol 19:671\u2013678. https:\/\/doi.org\/10.1038\/s41574-023-00883-8","journal-title":"Nat Rev Endocrinol"},{"key":"1682_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-021-02785-z","volume":"74","author":"A Giustina","year":"2021","unstructured":"Giustina A (2021) Pituitary adenoma\u2026 nomen omen? Endocrine 74:1\u20134. https:\/\/doi.org\/10.1007\/s12020-021-02785-z","journal-title":"Endocrine"},{"key":"1682_CR3","doi-asserted-by":"publisher","first-page":"bvaa205","DOI":"10.1210\/jendso\/bvaa205","volume":"5","author":"K Ho","year":"2021","unstructured":"Ho K, Fleseriu M, Kaiser U et al (2021) Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? J Endocr Soc 5:bvaa205. https:\/\/doi.org\/10.1210\/jendso\/bvaa205","journal-title":"J Endocr Soc"},{"key":"1682_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S2213-8587(23)00382-0","volume":"12","author":"KKY Ho","year":"2024","unstructured":"Ho KKY, Fleseriu M, Wass J et al (2024) A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol 12:209\u2013214. https:\/\/doi.org\/10.1016\/S2213-8587(23)00382-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1682_CR5","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1210\/clinem\/dgaf252","volume":"110","author":"M Araujo-Castro","year":"2025","unstructured":"Araujo-Castro M, Men\u00e9ndez Torre E, Lozano-Aida C et al (2025) Validation and limitations of the PANOMEN-3 predictive model for tumor recurrence and progression in pituitary tumors. J Clin Endocrinol Metab 110:3391\u20133399. https:\/\/doi.org\/10.1210\/clinem\/dgaf252","journal-title":"J Clin Endocrinol Metab"},{"key":"1682_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s12020-025-04292-x","volume":"89","author":"A Mondin","year":"2025","unstructured":"Mondin A, Bovo G, Barbot M et al (2025) PANOMEN-3 grading score is reliable in predicting pituitary adenoma behavior and prognosis: a single center cohort study. Endocrine 89:834\u2013845. https:\/\/doi.org\/10.1007\/s12020-025-04292-x","journal-title":"Endocrine"},{"key":"1682_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11102-025-01613-1","volume":"29","author":"Y Chen","year":"2025","unstructured":"Chen Y, Feng T, Fan D et al (2025) Validation and modification of the PANOMEN 3 classification for predicting long-term recurrence\/progression and quality of life in patients with pituitary adenomas: a multicentre retrospective cohort study. Pituitary 29:10. https:\/\/doi.org\/10.1007\/s11102-025-01613-1","journal-title":"Pituitary"},{"key":"1682_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01086-4","author":"N Qiao","year":"2020","unstructured":"Qiao N, Shen M, He W et al (2020) Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study. Pituitary. https:\/\/doi.org\/10.1007\/s11102-020-01086-4","journal-title":"Pituitary"},{"key":"1682_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9:847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1682_CR10","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ERJ, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"key":"1682_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/s-0043-1777264","volume":"19","author":"A Srivastava","year":"2024","unstructured":"Srivastava A, Singh M, Yadav A et al (2024) Does New WHO 2022 Nomenclature of Pituitary Neuroendocrine Tumors Offer an Extra Edge to the Neurosurgeons for Its Management? A Narrative Review. Asian J Neurosurg 19:107\u2013111. https:\/\/doi.org\/10.1055\/s-0043-1777264","journal-title":"Asian J Neurosurg"},{"key":"1682_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33:6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"issue":"5","key":"1682_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11102-025-01562-9","volume":"28","author":"S Chiloiro","year":"2025","unstructured":"Chiloiro S, Giampietro A, Migliore R et al (2025) The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort. Pituitary 28:97. https:\/\/doi.org\/10.1007\/s11102-025-01562-9","journal-title":"Pituitary"},{"key":"1682_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61111973","author":"A Kamel","year":"2025","unstructured":"Kamel A, Tataranu LG, Cristutiu B-C et al (2025) The pitNET puzzle: from zero to linking molecular behavior with neurosurgical aspects. Medicina Kaunas. https:\/\/doi.org\/10.3390\/medicina61111973","journal-title":"Medicina Kaunas"},{"key":"1682_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15:71\u201383. https:\/\/doi.org\/10.1007\/s11102-011-0347-7","journal-title":"Pituitary"},{"key":"1682_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/ejendo\/lvaf122","volume":"193","author":"P Fookeerah","year":"2025","unstructured":"Fookeerah P, Varikatt W, Shingde M et al (2025) Assessing the clinical application of the PANOMEN 3 classification in a large cohort of pituitary tumors. Eur J Endocrinol 193:56\u201364. https:\/\/doi.org\/10.1093\/ejendo\/lvaf122","journal-title":"Eur J Endocrinol"},{"key":"1682_CR17","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.3346\/jkms.2025.40.e56","volume":"40","author":"H Kim","year":"2025","unstructured":"Kim H, Kim EE, Kim YH et al (2025) Comprehensive Classification of Surgically Resected Pituitary Neuroendocrine Tumors: Updates From a Single-Institution Experience Based on the WHO 5th Edition. J Korean Med Sci 40:e56. https:\/\/doi.org\/10.3346\/jkms.2025.40.e56","journal-title":"J Korean Med Sci"},{"key":"1682_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11604-023-01412-3","volume":"41","author":"Y Fushimi","year":"2023","unstructured":"Fushimi Y, Taoka T, Naganawa S (2023) From pituitary adenoma to PitNET: it is time to discuss PitNET\/pituitary adenoma. Jpn J Radiol 41:787\u2013788. https:\/\/doi.org\/10.1007\/s11604-023-01412-3","journal-title":"Jpn J Radiol"},{"key":"1682_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jne.70078","volume":"37","author":"S Chiloiro","year":"2025","unstructured":"Chiloiro S, Vicari A, Giampietro A et al (2025) Tumor-infiltrating immune cells predict the response to somatostatin receptor ligands only in somatotropinomas na\u00efve to medical therapy. J Neuroendocrinol 37:e70078. https:\/\/doi.org\/10.1111\/jne.70078","journal-title":"J Neuroendocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01682-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:19Z","timestamp":1782409759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01682-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01682-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was given for this retrospective single-center clinical study on March 14, 2024 (approval number: 2024\/02\/24\u201350) by the Istinye University Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent obtained from the patient for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare that they have used OpenAI (ChatGPT) for grammar checking and syntax improvement.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement about the use of AI"}}],"article-number":"74"}}